Amy Simon

40 papers receiving 3.0k citations

Amy Simon's Hit Papers

A Highly Durable RNAi Therapeutic Inhibitor of PCSK9 2016 · 586 citations
5860+4+8Years since publication100200300400500

Peers

Amy Simon
Comparison fields: 5 of 110
  • Cancer Research 466
  • Immunology 588
  • Molecular Biology 1.5k
  • Oncology 483
  • Surgery 744
Replace Jiawei Chen with:
Jiawei Chen China
Masatoshi Kusuhara Japan
Alistair J. Ingram Canada
Yabing Chen United States
Linda A. Gleaves United States
Aijun Sun China
Motoi Ohba Japan
Heidi S. Camp United States
Zheng‐Gen Jin United States
Rossella Menghini Italy
Amy Simon relative to Jiawei Chen China Jiawei Chen's profile →
Citations per field
00.5×1.5×1.9×
Jiawei Chen · 1×
Citations per year

Countries citing papers authored by Amy Simon

Since Specialization
Citations

This map shows the geographic impact of Amy Simon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Simon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Simon more than expected).

Fields of papers citing papers by Amy Simon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Simon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Simon. The network helps show where Amy Simon may publish in the future.

Co-authors

The 25 scholars most cited alongside Amy Simon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Amy Simon Line = papers co-authored together Amy Simon links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A Highly Durable RNAi Therapeutic Inhibitor of PCSK9
Hit paper breakdown →
2016586
2 1998499
3
Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial
Hit paper breakdown →
2013467
4 2000194
5 2004147
6 2003145
7 2007121
8 2015120
9 2015108
10 200299
11 202087
12 200583
13 200869
14 200159
15 199652
16 201851
17 200845
18 202122
19 200520
20
Results of a phase 2b multi-center trial of ALN-RSV01 in respiratory syncytial virus (RSV)-infected lung transplant patients
201215

About Amy Simon

Amy Simon is a scholar working on Molecular Biology, Surgery, Oncology, Cardiology and Cardiovascular Medicine and Cancer Research, having authored 42 papers that have together received 3.1k indexed citations. Recurring topics across this work include Porphyrin Metabolism and Disorders (12 papers), Heme Oxygenase-1 and Carbon Monoxide (8 papers), Cytokine Signaling Pathways and Interactions (7 papers), Neonatal Health and Biochemistry (5 papers), Folate and B Vitamins Research (5 papers), NF-κB Signaling Pathways (4 papers), Genomics, phytochemicals, and oxidative stress (4 papers) and Transplantation: Methods and Outcomes (3 papers). The work is most often cited by research in Cancer Research (466 citations), Immunology (588 citations), Molecular Biology (1.5k citations), Oncology (483 citations) and Surgery (744 citations). Amy Simon has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Brent Cochran, Barry L. Fanburg, Usha Rai, Mariano Severgnini, Valerie A. Clausen, Akshay Vaishnaw, Kevin Fitzgerald, Brian R. Bettencourt, Jay D. Horton and Satoe Takahashi. Their work appears in journals such as Blood, American Journal of Physiology-Lung Cellular and Molecular Physiology, Clinical Pharmacology & Therapeutics, Arteriosclerosis Thrombosis and Vascular Biology and Molecular Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact